• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    10x Genomics Secures Distributors for the Asia-Pacific Region

    Investing News Network
    May. 11, 2016 08:55AM PST
    Biotech Investing

    PLEASANTON, Calif.–(BUSINESS WIRE)–10x Genomics, Inc., today announced that it has entered into distribution agreements with MDxK, Inc., Millennium Science Pty Ltd, Research Instruments Pte Ltd, and Star Research Technology Ltd., for the promotion, sales, and support of 10x’s ChromiumTM System and associated products to address long range and single cell genomic applications in Asia and …

    PLEASANTON, Calif.–(BUSINESS WIRE)–10x Genomics, Inc., today announced that it has entered into
    distribution agreements with MDxK, Inc., Millennium Science Pty Ltd,
    Research Instruments Pte Ltd, and Star Research Technology Ltd., for the
    promotion, sales, and support of 10x’s ChromiumTM System and
    associated products to address long range and single cell genomic
    applications in Asia and Pacific Rim markets (APAC).
    The distribution agreements cover South Korea (MDxK), Australia and New
    Zealand (Millennium Science), Southeast Asia (Research Instruments), and
    China (Star Research Technology).
    “The Asia-Pacific region is experiencing significant growth across all
    areas of genomics spurring demand for solutions that provide full
    sequence information and genomic analysis at single cell resolution,”
    said Dr. Serge Saxonov, 10x’s Chief Executive Officer, “we are thrilled
    to welcome Millennium Science, MDxK, Research Instruments, and Star
    Research Technology, each premier life science instrumentation
    distributors in their respective regions, as key partners to 10x. These
    partnerships represent an important step in the global commercial
    expansion of 10x, and working together, we will be able to better serve
    our customers’ needs in the Asia-Pacific region.”
    10x’s microfluidics-based molecular barcoding solutions, built on the
    proprietary GemCode™ Technology, provide researchers critical long-range
    sequence information through existing sequencing workflows. The Chromium
    Genome and Exome Solutions together include phasing, structural variant
    analysis, de novo genome assembly, and remapping of difficult
    regions of the genome. In addition, 10x’s recently introduced Chromium
    Single Cell Solution allows for rapid and comprehensive analysis of
    dynamic transcription events from large numbers of individual cells.
    “We are excited to be working with 10x to bring the Chromium System to
    market and introduce important new dimensions to our customers’
    research”, said Steven Qiu, Chief Executive Officer of Star Research
    Technology. “10x Genomics is recognized for delivering critical enabling
    applications, including long-range sequence information and
    high-throughput single cell analysis. This partnership will enable our
    NGS customers to access 10x’s linked-read sequencing products and
    significant new capabilities that will power further advances in single
    cell biology and genomic research.”
    10x Genomics distributor information can be found at 10xGenomics.com/distributors.
    About 10x Genomics
    10x Genomics is changing the definition of sequencing by providing an
    innovative genomics platform that dramatically upgrades the capabilities
    of existing sequencing technologies. This is achieved through a
    combination of new microfluidic science, chemistry and bioinformatics.
    By implementing GemCodeTM Technology within the Chromium
    System, researchers can now, for the first time, find new structural
    variants, haplotypes, and other valuable genomic information with
    comprehensive workflows for Single Cell, Genome and Exome applications
    that incorporate their pre-existing sequencing technologies.

    australiachina
    The Conversation (0)

    Go Deeper

    AI Powered
    Microscopic view of stem cells.

    Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

    Senior woman doing exercises alongside closeup of DNA.

    5 US Longevity and Anti-aging Stocks to Watch in 2025

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×